中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
3期
169-170,171
,共3页
输卵管妊娠%米非司酮%氨甲喋呤
輸卵管妊娠%米非司酮%氨甲喋呤
수란관임신%미비사동%안갑첩령
Tubal pregnanc%Mifepristone%Methotrexate
目的总结输卵管妊娠患者的临床治疗体会。方法选取2013年5月~2014年5月间我院收治的输卵管妊娠患者47例,对照组单纯给予氨甲喋呤肌注治疗,实验组给予氨甲喋呤与米非司酮配伍治疗,比较两组血清β-HCG恢复时间及总有效率。结果实验组血清β-HCG恢复时间(9.1±1.4)d少于对照组(18.1±2.6)d,总有效率(92.00%)相对较高,两组患者临床疗效差异显著,有统计学意义(P<0.05)。结论输卵管妊娠应用氨甲喋呤与米非司酮配伍治疗效果良好,安全无创。
目的總結輸卵管妊娠患者的臨床治療體會。方法選取2013年5月~2014年5月間我院收治的輸卵管妊娠患者47例,對照組單純給予氨甲喋呤肌註治療,實驗組給予氨甲喋呤與米非司酮配伍治療,比較兩組血清β-HCG恢複時間及總有效率。結果實驗組血清β-HCG恢複時間(9.1±1.4)d少于對照組(18.1±2.6)d,總有效率(92.00%)相對較高,兩組患者臨床療效差異顯著,有統計學意義(P<0.05)。結論輸卵管妊娠應用氨甲喋呤與米非司酮配伍治療效果良好,安全無創。
목적총결수란관임신환자적림상치료체회。방법선취2013년5월~2014년5월간아원수치적수란관임신환자47례,대조조단순급여안갑첩령기주치료,실험조급여안갑첩령여미비사동배오치료,비교량조혈청β-HCG회복시간급총유효솔。결과실험조혈청β-HCG회복시간(9.1±1.4)d소우대조조(18.1±2.6)d,총유효솔(92.00%)상대교고,량조환자림상료효차이현저,유통계학의의(P<0.05)。결론수란관임신응용안갑첩령여미비사동배오치료효과량호,안전무창。
Objective Clinical treatment experience of patients with tubal pregnancy is to be summarized. Methods Choose 47 patients of tubal pregnancy who are treated in hospital from May 2013 to May 2014 and separate them into two groups;patients in control group are given intramuscular methotrexate treatment,while patients in study group are given methotrexate combined with mifepristone treatment and then compareβ-HCG recovery time and treatment efficacy between two groups. Results The comparative result shows that β-HCG recovery time in study group (9.1±1.4)d is much less than that in control group(18.1±2.6)d,and in addition, treatment efficacy in study group (92.00%) is much higher; there is a treatment differential between two groups,and such a differential has statistic value(P<0.05). Conclusion Methotrexate combined with mifepristone treatment is of efficiency and medication safety in treatment of tubal pregnancy,it is quite worthwhile to be applied clinical y.